Aptose Biosciences Inc (APS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.381x

Based on the latest financial reports, Aptose Biosciences Inc (APS) has a cash flow conversion efficiency ratio of 0.381x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-7.41 Million ≈ $-5.36 Million USD) by net assets (CA$-19.45 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see APS market cap overview for the company's overall valuation and market capitalisation.

Aptose Biosciences Inc - Cash Flow Conversion Efficiency Trend (1996–2024)

This chart illustrates how Aptose Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aptose Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aptose Biosciences Inc ranked by their cash flow conversion efficiency. Explore how high is Aptose Biosciences Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
PDZ Holdings Bhd KLSE:6254	0.132x
Visible Gold Mines Inc V:VGD	-0.072x
Bank Mayapada Internasional JK:MAYA	-0.128x
Bitterroot Resources Ltd V:BTT	-0.003x
Clara Resources Australia Ltd AU:C7A	-0.096x
Eka Sari Lorena Transport Tbk JK:LRNA	-0.019x
Creative Global Technology Holdings Limited Ordinary Shares NASDAQ:CGTL	-0.001x
Roadman Investments Corp V:LITT	-0.065x

Annual Cash Flow Conversion Efficiency for Aptose Biosciences Inc (1996–2024)

The table below shows the annual cash flow conversion efficiency of Aptose Biosciences Inc from 1996 to 2024. View APS stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-4.54 Million ≈ $-3.29 Million	CA$-35.98 Million ≈ $-26.03 Million	7.919x	-48.48%
2023-12-31	CA$-2.90 Million ≈ $-2.10 Million	CA$-44.59 Million ≈ $-32.26 Million	15.371x	+1894.75%
2022-12-31	CA$37.74 Million ≈ $27.30 Million	CA$-32.32 Million ≈ $-23.38 Million	-0.856x	-46.82%
2021-12-31	CA$74.24 Million ≈ $53.70 Million	CA$-43.30 Million ≈ $-31.33 Million	-0.583x	-104.68%
2020-12-31	CA$118.92 Million ≈ $86.02 Million	CA$-33.89 Million ≈ $-24.52 Million	-0.285x	-24.17%
2019-12-31	CA$93.93 Million ≈ $67.94 Million	CA$-21.56 Million ≈ $-15.59 Million	-0.230x	+86.07%
2018-12-31	CA$14.08 Million ≈ $10.19 Million	CA$-23.21 Million ≈ $-16.79 Million	-1.648x	-64.47%
2017-12-31	CA$10.20 Million ≈ $7.38 Million	CA$-10.22 Million ≈ $-7.40 Million	-1.002x	+39.69%
2016-12-31	CA$7.33 Million ≈ $5.30 Million	CA$-12.17 Million ≈ $-8.81 Million	-1.661x	-129.30%
2015-12-31	CA$13.65 Million ≈ $9.87 Million	CA$-9.89 Million ≈ $-7.15 Million	-0.725x	-84.19%
2014-12-31	CA$25.28 Million ≈ $18.28 Million	CA$-9.94 Million ≈ $-7.19 Million	-0.393x	-106.04%
2013-12-31	CA$-757.75K ≈ $-548.15K	CA$-4.94 Million ≈ $-3.57 Million	6.516x	+296.38%
2012-12-31	CA$-1.95 Million ≈ $-1.41 Million	CA$-3.21 Million ≈ $-2.32 Million	1.644x	+106.67%
2011-12-31	CA$244.66K ≈ $176.99K	CA$-6.03 Million ≈ $-4.36 Million	-24.661x	-459.21%
2010-12-31	CA$-513.68K ≈ $-371.59K	CA$-3.53 Million ≈ $-2.55 Million	6.865x	+694.85%
2009-12-31	CA$-7.66 Million ≈ $-5.54 Million	CA$-6.62 Million ≈ $-4.79 Million	0.864x	-67.36%
2008-12-31	CA$-3.87 Million ≈ $-2.80 Million	CA$-10.25 Million ≈ $-7.42 Million	2.646x	+131.98%
2007-12-31	CA$711.16K ≈ $514.45K	CA$-5.88 Million ≈ $-4.26 Million	-8.274x	-261.85%
2006-12-31	CA$-2.32 Million ≈ $-1.68 Million	CA$-11.87 Million ≈ $-8.58 Million	5.112x	+462.25%
2005-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	0.00%
2004-12-31	CA$10.57 Million ≈ $7.65 Million	CA$-14.92 Million ≈ $-10.79 Million	-1.411x	-43.83%
2003-12-31	CA$20.99 Million ≈ $15.19 Million	CA$-20.60 Million ≈ $-14.90 Million	-0.981x	-263.72%
2002-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	0.00%
2001-12-31	CA$28.89 Million ≈ $20.90 Million	CA$-7.79 Million ≈ $-5.64 Million	-0.270x	-56.21%
2000-12-31	CA$36.38 Million ≈ $26.32 Million	CA$-6.28 Million ≈ $-4.55 Million	-0.173x	-121.46%
1999-12-31	CA$45.89 Million ≈ $33.19 Million	CA$-3.58 Million ≈ $-2.59 Million	-0.078x	+95.88%
1998-12-31	CA$1.29 Million ≈ $932.14K	CA$-2.44 Million ≈ $-1.77 Million	-1.895x	-106.70%
1997-12-31	CA$3.30 Million ≈ $2.38 Million	CA$-3.02 Million ≈ $-2.19 Million	-0.917x	-141.90%
1996-12-31	CA$6.89 Million ≈ $4.99 Million	CA$-2.61 Million ≈ $-1.89 Million	-0.379x	--

About Aptose Biosciences Inc

TO:APS Canada Biotechnology

Market Cap

$4.43 Million

CA$6.13 Million CAD

Market Cap Rank

#28910 Global

#1306 in Canada

Share Price

CA$2.40

Change (1 day)

+0.00%

52-Week Range

CA$1.57 - CA$2.40

All Time High

CA$181.05